Tweet Archive for January 2019 « page 11
#PsoriasisAwareness – New warning for #ustekinumab users regarding the risk of developing noninfectious pneumonia.…
https://twitter.com/i/web/status/1083720057753096192
#EpidermolysisBullosaAwareness Epidermolysis Bullosa #dermatology #dermatologia
Listen to this author interview with Anna Bruckner, MD, MSCS, discussing milestone clinical events in patients with epidermolysis bullosa https://t.co/nchTQqti6B #podcast #audio pic.twitter.com/SXaobIaT6K
— JAMA Dermatology (@JAMADerm) January 2, 2019
@aaron_drucker @JIDJournal FYI @anneklassen
@aaron_drucker @BrJDermatol Thank you for your post. I was not aware that the sponsor a respected Korean skin care…
https://twitter.com/i/web/status/1083672143941062656
RT @JAMADerm: Detection bias is an important issue to consider in epidemiologic studies of skin cancer risk from @aaron_drucker and colleag…
JAMA #Dermatology Highlights #melanoma #skincancer #eczema #dermatologia
In This Issue of JAMA Dermatology: Talimogene Laherparepvec–Ipilimumab for #Melanoma, Persistent Atopic #Dermatitis in Children, and more. https://t.co/a8d958av8X
— JAMA Dermatology (@JAMADerm) January 9, 2019
RT @JAMA_current: This @MedicalLetter review summarizes the mechanism of action, adverse effects, and dose and administration of a recently…
Molecule discovery holds promise for gene therapies for #psoriasis sciencedaily.com/releases/2018/… #dermatology #dermatologia #genes
#VitiligoAwareness
Factors affecting quality of life in patients with vitiligo: a nationwide study…
https://twitter.com/i/web/status/1083438125572071425
The Impact of Stress on Epidermal Barrier Function — An Evidence‐Based Review onlinelibrary.wiley.com/doi/10.1111/bj…
#dermatology…
https://twitter.com/i/web/status/1083436407975301122